Question 1

What are the potential side effects of HT-100?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy clinical trial (NCT01847573). Contact the study team or your healthcare provider for specific answers.

Question 2

How does HT-100 compare to other treatments I might be considering?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy clinical trial (NCT01847573). Contact the study team or your healthcare provider for specific answers.

Question 3

What will the process be for monitoring my health during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy clinical trial (NCT01847573). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits or tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy clinical trial (NCT01847573). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I experience side effects while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy clinical trial (NCT01847573). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any costs associated with participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of HT-100 in Duchenne Muscular Dystrophy clinical trial (NCT01847573). Contact the study team or your healthcare provider for specific answers.

What this study is about